0001685619-22-000003.txt : 20220406 0001685619-22-000003.hdr.sgml : 20220406 20220406154755 ACCESSION NUMBER: 0001685619-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220406 DATE AS OF CHANGE: 20220406 EFFECTIVENESS DATE: 20220406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acuamark Diagnostics, Inc. CENTRAL INDEX KEY: 0001685619 IRS NUMBER: 461181186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-440683 FILM NUMBER: 22810506 BUSINESS ADDRESS: STREET 1: 101 AVENUE OF THE AMERICAS STREET 2: FLOOR 3 (C/O JLABS) CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 646-640-7865 MAIL ADDRESS: STREET 1: 101 AVENUE OF THE AMERICAS STREET 2: FLOOR 3 (C/O JLABS) CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0001685619 Acuamark Diagnostics, Inc. 101 Avenue of the Americas Floor 3 (c/o JLABS) NEW YORK NY NEW YORK 10013 646-640-7865 DELAWARE iCareDx, Inc. None Corporation true Bernard Peperstraete 101 Avenue of the Americas Floor 3 (c/o JLABS) New York NY NEW YORK 10013 Executive Officer Director Promoter William Gedale 101 Avenue of the Americas Floor 3 (c/o JLABS) New York NY NEW YORK 10013 Director Claudio Del Vecchio 101 Avenue of the Americas Floor 3 (c/o JLABS) New York NY NEW YORK 10013 Director Vanja Vuletic 101 Avenue of the Americas Floor 3 (c/o JLABS) New York NY NEW YORK 10013 Director Cedric Francois 101 Avenue of the Americas Floor 3 (c/o JLABS) New York NY NEW YORK 10013 Director Other Health Care Decline to Disclose 06b false 2022-03-21 false true false 0 13648253 11623242 2025011 The total offering amount and amount sold includes 3,648,253 representing the conversion of outstanding convertible securities. false 41 0 148750 true 0 false Acuamark Diagnostics, Inc. /s/ Bernard Peperstraete Bernard Peperstraete Chief Executive Officer 2022-04-06